Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Prince Pharmaceutical Co., Ltd. (6935:TWSE), powered by AI.
Prince Pharmaceutical Co., Ltd. is currently trading at $29.65. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Prince Pharmaceutical Co., Ltd. on Alpha Lenz.
View Prince Pharmaceutical Co., Ltd.'s valuation metrics on Alpha Lenz.
“Prince Pharmaceutical Co., Ltd.'s ROE is 12.3%. Explore profitability and growth together.”
Ask for details →Prince Pharmaceutical Co., Ltd. is a healthcare company specializing in the manufacture and sale of active pharmaceutical ingredients, with a notable focus on vitamin B1 products. Established in 1962 and headquartered in Yunlin County, Taiwan, the company has expanded its reach to multiple international markets, including Japan, Korea, Spain, and several European countries. Beyond pharmaceutical ingredients, Prince Pharmaceutical Co., Ltd. offers a portfolio of health food items such as vitamin C and B complex tablets, plant extract capsules, natto and rhodiola extract capsules, and probiotic sachets. The business operates across key segments including health foods and Western medicine, with health food products representing a steadily growing share of its revenues. As a supplier to both domestic and overseas clients, the company plays a vital role in the broader pharmaceutical and specialty drug sector, supporting healthcare distribution and manufacturing chains in Asia and beyond.
“Prince Pharmaceutical Co., Ltd.'s ROE is 12.3%. Explore profitability and growth together.”
Ask for details →Prince Pharmaceutical Co., Ltd. (ticker: 6935) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 210 employees.
The current price is 29.65 with a P/E ratio of -x and P/B of -x.
ROE is 12.34% and operating margin is 10.50%. Annual revenue is $1.1B.